TherapeuticsMD, Inc. Stock-Based Compensation
TherapeuticsMD, Inc. (TXMD) reported Stock-Based Compensation of $6.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.00K, a 300.00% increase year-over-year.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.00K, a 91.30% decline year-over-year.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $51.00K, a 112.50% increase year-over-year.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $75.00K, a 71.59% decline from fiscal 2024.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $264.00K, a 79.23% decline from fiscal 2023.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.27M, a 89.02% decline from fiscal 2022.
- TherapeuticsMD, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $11.57M, a 36.15% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $6.00K 10-Q · filed 2026-08-11 | $57.00K derived: sum of 3 quarters · filed 2026-08-11 | $57.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-12 | $53.00K derived: sum of 2 quarters · filed 2026-05-12 | $53.00K derived: sum of 3 quarters · filed 2026-05-12 | $54.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $51.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-01 | $51.00K derived: sum of 2 quarters · filed 2026-04-01 | $52.00K derived: sum of 3 quarters · filed 2026-08-11 | $75.00K 10-K/A · filed 2026-04-01 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.00K derived: sum of 2 quarters · filed 2026-08-11 | $24.00K 10-Q · filed 2025-11-12 | $48.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $24.00K 10-Q · filed 2026-08-11 | $48.00K derived: sum of 3 quarters · filed 2026-08-11 | $81.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $23.00K 10-Q · filed 2026-05-12 | $47.00K derived: sum of 2 quarters · filed 2026-05-12 | $80.00K derived: sum of 3 quarters · filed 2026-05-12 | $176.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $24.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-01 | $57.00K derived: sum of 2 quarters · filed 2026-04-01 | $153.00K derived: sum of 3 quarters · filed 2026-04-01 | $264.00K 10-K/A · filed 2026-04-01 | ||||
| 2024-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $129.00K derived: sum of 2 quarters · filed 2025-11-12 | $240.00K 10-Q · filed 2025-11-12 | $356.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $207.00K 10-Q · filed 2025-08-12 | $323.00K derived: sum of 3 quarters · filed 2025-08-12 | $557.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $111.00K 10-Q · filed 2025-05-13 | $227.00K derived: sum of 2 quarters · filed 2025-05-13 | $461.00K derived: sum of 3 quarters · filed 2025-05-13 | $899.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $350.00K derived: sum of 2 quarters · filed 2025-03-27 | $788.00K derived: sum of 3 quarters · filed 2025-03-27 | $1.27M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $672.00K derived: sum of 2 quarters · filed 2024-08-12 | $1.16M 10-Q · filed 2023-11-14 | $4.14M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $921.00K 10-Q · filed 2024-08-12 | $3.91M derived: sum of 3 quarters · filed 2024-08-12 | $8.20M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $483.00K 10-Q · filed 2023-05-15 | $3.47M derived: sum of 2 quarters · filed 2024-03-29 | $7.76M derived: sum of 3 quarters · filed 2024-03-29 | $9.99M derived: sum of 4 quarters · filed 2024-03-29 | ||||
| 2022-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $7.28M derived: sum of 2 quarters · filed 2024-03-29 | $9.51M derived: sum of 3 quarters · filed 2024-03-29 | $11.57M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.53M derived: sum of 2 quarters · filed 2023-11-14 | $8.59M 10-Q · filed 2023-11-14 | $13.93M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.29M 10-Q · filed 2023-08-14 | $4.28M 10-Q · filed 2022-08-15 | $9.64M derived: sum of 3 quarters · filed 2023-08-14 | $16.95M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $2.06M 10-Q · filed 2023-05-15 | $2.06M 10-Q · filed 2022-05-16 | $7.41M derived: sum of 2 quarters · filed 2023-05-15 | $14.72M derived: sum of 3 quarters · filed 2023-05-15 | $17.23M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-07 | $12.66M derived: sum of 2 quarters · filed 2023-04-07 | $15.17M derived: sum of 3 quarters · filed 2023-04-07 | $18.13M 10-K · filed 2023-04-07 | ||||
| 2021-09-30 | $7.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.82M derived: sum of 2 quarters · filed 2022-11-14 | $12.78M 10-Q · filed 2022-11-14 | $14.96M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $5.47M 10-Q · filed 2022-08-15 | $7.64M derived: sum of 3 quarters · filed 2022-08-15 | $10.78M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $2.96M 10-Q · filed 2022-05-16 | $5.13M derived: sum of 2 quarters · filed 2022-05-16 | $8.27M derived: sum of 3 quarters · filed 2022-05-16 | $11.27M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $5.31M derived: sum of 2 quarters · filed 2022-03-23 | $8.31M derived: sum of 3 quarters · filed 2022-03-23 | $10.68M 10-K · filed 2022-03-23 | $10.68M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $6.14M derived: sum of 2 quarters · filed 2021-11-12 | $8.50M 10-Q · filed 2021-11-12 | $8.50M 10-Q · filed 2020-11-09 | $11.32M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.37M 10-Q · filed 2021-08-04 | $5.37M 10-Q · filed 2020-08-07 | $8.19M derived: sum of 3 quarters · filed 2022-03-23 | $10.83M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2020-03-31 | $2.37M 10-Q · filed 2021-05-06 | $2.37M 10-Q · filed 2020-05-06 | $5.19M derived: sum of 2 quarters · filed 2022-03-23 | $7.82M derived: sum of 3 quarters · filed 2022-03-23 | $10.46M derived: sum of 4 quarters · filed 2022-03-23 | |||
| 2019-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $5.46M derived: sum of 2 quarters · filed 2022-03-23 | $8.10M derived: sum of 3 quarters · filed 2022-03-23 | $10.68M 10-K · filed 2022-03-23 | $10.69M 10-K · filed 2020-02-24 | |||
| 2019-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.27M derived: sum of 2 quarters · filed 2020-11-09 | $7.86M 10-Q · filed 2020-11-09 | $10.13M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $5.22M 10-Q · filed 2020-08-07 | $7.50M derived: sum of 3 quarters · filed 2021-03-04 | $9.76M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $2.59M 10-Q · filed 2020-05-06 | $4.86M derived: sum of 2 quarters · filed 2021-03-04 | $7.12M derived: sum of 3 quarters · filed 2021-03-04 | $9.50M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $4.53M derived: sum of 2 quarters · filed 2021-03-04 | $6.91M derived: sum of 3 quarters · filed 2021-03-04 | $8.66M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $4.64M derived: sum of 2 quarters · filed 2019-11-08 | $6.39M 10-Q · filed 2019-11-08 | $8.24M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $4.13M 10-Q · filed 2019-08-09 | $5.98M derived: sum of 3 quarters · filed 2020-02-24 | $7.97M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $1.75M 10-Q · filed 2019-05-08 | $3.60M derived: sum of 2 quarters · filed 2020-02-24 | $5.59M derived: sum of 3 quarters · filed 2020-02-24 | $7.23M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $3.84M derived: sum of 2 quarters · filed 2020-02-24 | $5.48M derived: sum of 3 quarters · filed 2020-02-24 | $6.89M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.62M derived: sum of 2 quarters · filed 2018-11-08 | $5.04M 10-Q · filed 2018-11-08 | $9.06M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $3.05M 10-Q · filed 2018-07-30 | $7.08M derived: sum of 3 quarters · filed 2019-02-27 | $11.26M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $1.41M 10-Q · filed 2018-05-07 | $5.44M derived: sum of 2 quarters · filed 2019-02-27 | $9.62M derived: sum of 3 quarters · filed 2019-02-27 | $14.44M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $8.21M derived: sum of 2 quarters · filed 2019-02-27 | $13.03M derived: sum of 3 quarters · filed 2019-02-27 | $17.41M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $9.00M derived: sum of 2 quarters · filed 2017-11-07 | $13.39M 10-Q · filed 2017-11-07 | $15.83M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $9.20M 10-Q · filed 2017-08-03 | $11.65M derived: sum of 3 quarters · filed 2018-02-23 | $13.42M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $4.38M 10-Q · filed 2017-05-03 | $6.83M derived: sum of 2 quarters · filed 2018-02-23 | $8.60M derived: sum of 3 quarters · filed 2018-02-23 | $10.73M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $4.22M derived: sum of 2 quarters · filed 2018-02-23 | $6.35M derived: sum of 3 quarters · filed 2018-02-23 | $7.19M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $3.90M derived: sum of 2 quarters · filed 2016-11-04 | $4.74M 10-Q · filed 2016-11-04 | $5.78M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.97M 10-Q · filed 2016-08-05 | $2.05M 10-Q · filed 2015-08-07 | $4.00M derived: sum of 3 quarters · filed 2017-02-28 | $5.67M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $840.46K 10-Q · filed 2016-05-05 | $704.87K 10-Q · filed 2015-05-07 | $1.88M derived: sum of 2 quarters · filed 2017-02-28 | $3.54M derived: sum of 3 quarters · filed 2017-02-28 | $4.80M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.70M derived: sum of 2 quarters · filed 2017-02-28 | $3.96M derived: sum of 3 quarters · filed 2017-02-28 | $4.97M 10-K · filed 2017-02-28 | $4.24M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $2.93M derived: sum of 2 quarters · filed 2015-11-05 | $3.93M 10-Q · filed 2015-11-05 | $3.23M 10-Q · filed 2014-11-07 | $5.85M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $2.27M 10-Q · filed 2015-08-07 | $4.19M derived: sum of 3 quarters · filed 2016-02-26 | $4.93M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $1.01M 10-Q · filed 2015-05-07 | $2.93M derived: sum of 2 quarters · filed 2016-02-26 | $3.67M derived: sum of 3 quarters · filed 2016-02-26 | $4.31M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.66M derived: sum of 2 quarters · filed 2016-02-26 | $3.30M derived: sum of 3 quarters · filed 2016-02-26 | $3.84M 10-K · filed 2016-02-26 | $3.21M 10-K · filed 2014-03-05 | |||
| 2013-09-30 | $747.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.38M derived: sum of 2 quarters · filed 2014-11-07 | $1.93M 10-Q · filed 2014-11-07 | $2.76M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $637.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.18M 10-Q · filed 2014-08-07 | $2.02M derived: sum of 3 quarters · filed 2015-03-12 | $2.52M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $542.38K 10-Q · filed 2014-05-07 | $609.03K 10-Q · filed 2013-05-10 | $1.38M derived: sum of 2 quarters · filed 2015-03-12 | $1.88M derived: sum of 3 quarters · filed 2015-03-12 | $2.32M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $836.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.34M derived: sum of 2 quarters · filed 2015-03-12 | $1.78M derived: sum of 3 quarters · filed 2015-03-12 | $1.87M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $502.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $943.10K derived: sum of 2 quarters · filed 2013-11-05 | $1.03M 10-Q · filed 2013-11-05 | $1.07M derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-06-30 | $440.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $529.13K 10-Q · filed 2013-08-07 | $566.82K derived: sum of 3 quarters · filed 2014-03-05 | $621.41K derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2012-03-31 | $88.58K 10-Q · filed 2013-05-10 | $126.27K derived: sum of 2 quarters · filed 2014-03-05 | $180.86K derived: sum of 3 quarters · filed 2014-03-05 | $226.83K derived: sum of 4 quarters · filed 2014-03-05 | ||||
| 2011-12-31 | $37.69K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $92.28K derived: sum of 2 quarters · filed 2014-03-05 | $138.25K derived: sum of 3 quarters · filed 2014-03-05 | $190.51K 10-K · filed 2014-03-05 | ||||
| 2011-09-30 | $54.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $100.56K derived: sum of 2 quarters · filed 2012-11-13 | $152.82K 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | $45.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $98.24K 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | $52.27K 10-Q · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |